Search results
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Investor's Business Daily· 2 years agoMerck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Zacks via Yahoo Finance· 2 years agoMerck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to...
The secret to breaking down the high price of prescription drugs
WPXI via Yahoo News· 1 year agoAn investigation has uncovered the secret to many newer name-brand medications. Some of these...
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
Reuters via Yahoo Finance· 2 years agoA Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...
Pharma CEOs grilled by senators over sky-high drug prices
NBC News via Yahoo News· 3 months agoWASHINGTON — Lawmakers sharply criticized the CEOs of three major drugmakers during a Senate...
Important News Update: How To Save on All of Your Prescriptions
First for Women via Yahoo News· 8 months agoOn August 29, 2023, the Biden administration unveiled the first 10 drugs that will be subjects of...
Medicare's drug pricing list didn't impact company stocks — here's why
Yahoo Finance· 8 months agoInvestor sentiment was indifferent towards the historic announcement Tuesday by the Biden...
Medicare recipients say new drug price negotiations will save them thousands
ABC News via Yahoo News· 8 months agoEvery month, Dawn LaGuerre has to decide which bills she's going to pay or if she needs to cut back...
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Motley Fool· 8 months agoAbout a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 8 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...